Can one assess whether missing data are missing at random in medical studies?
For handling missing data, newer methods such as those based on multiple imputation are generally more accurate than older ones and entail weaker assumptions. Yet most do assume that data are missing at random (MAR). The issue of assessing whether the MAR assumption holds to begin with has been largely ignored. In fact, no way to directly test MAR is available. We propose an alternate assumption, MAR+, that can be tested. MAR+ always implies MAR, so inability to reject MAR+ bodes well for MAR. In contrast, MAR implies MAR+ not universally, but under certain conditions that are often plausible; thus, rejection of MAR+ can raise suspicions about MAR. Our approach is applicable mainly to studies that are not longitudinal. We present five illustrative medical examples, in most of which it turns out that MAR+ fails. There are limits to the ability of sophisticated statistical methods to correct for missing data. Efforts to try to prevent missing data in the first place should therefore receive more attention in medical studies than they have heretofore attracted. If MAR+ is found to fail for a study whose data have already been gathered, extra caution may need to be exercised in the interpretation of the results.
Potthoff
Richard F
RF
Duke Clinical Research Institute, Duke University Medical Center, Durham, NC 27715, USA.
Tudor
Gail E
GE
Pieper
Karen S
KS
Hasselblad
Vic
V
D035843:Biomedical Research; D002986:Clinical Trials as Topic; D003627:Data Interpretation, Statistical; D006801:Humans; D015233:Models, Statistical